Dr DJ Hamblin-Brown
Chief Executive Officer
DJ is a member of the Royal College of Emergency Medicine and has worked for many years at consultant level in Emergency Medicine within the UK NHS.
Most recently, he was Vice President for Medical Affairs at UFH – a 7-hospital system in China – and was Group Medical Director for Aspen Healthcare in the UK.
His pre-medical training was in Computer Science and Engineering
Business Development Director
Mike provides a depth of commercial experience and customer understanding developed from working across all aspects of the healthcare sector.
Most recently working with Doctor Care Anywhere, Mike was previously the Commercial & Business Development Director for King Edward VII’s Hospital, during a period of rapid development. Prior to that he built his understanding of the healthcare markets working for Nuffield Health and AVIVA Health UK.
Chief Technology Officer
Simon has significant experience of systems integration within healthcare and has many years experience as IT designer, solutions developer and IT manager.
He has worked as an IT architect and systems designer at Apple, Booz Allen and Hamilton and for more than eight years at Microsoft.
Simon has a passion for improving patient care, having originally qualified as a radiographer.
David is a strategic communications expert who has worked with companies and individuals across a variety of sectors to help organisations connect with their customers and users.
He has brought important stories to a wide audience and has won awards for his documentary film making.
Head of User Engagement
Gina is orgininaly from Mexico City, where she studied graphic design and designed large format advertising campaigns. After moving to the UK she worked in retail management and visual merchandising.
Gina speaks four languages fluently, and has taught English as a second language (ESL). Now, based in Italy, she contributes to our localisation and translation work.
She provides Careful with its online presence on major social media platforms.
Tom has deep technical knowledge of scalable computing and extensive Typescript, React and Node expertise.
He has a strong academic background in computer systems engineering with research qualifications from both Australia and Europe.
Jonny is a senior software engineer with ten years’ experience working with a wide variety of tech stacks and languages with particular expertise in Elixir, React, and Typescript.
He has experience with all parts of the development lifecycle, from design to deployment.
Dr Nadeem Moghal
Nadeem is Chief Executive of DMC Healthcare in London which provides primary, specialist and community services for the NHS. He has had over 30 years of uniquely diverse clinical, academic and transformation work.
Dr Gbenga Afolabi
Gbenga has been a respiratory physician in the NHS for over 30 years and was MD of Northumbria Healthcare. He has worked in Nigeria, Belgium and Zimbabwe. He is a strong believer that IT can facilitate global and universal healthcare.
Ms Cédriane de Boucard
Cédriane is a founder and senior partner of Disruptive Capital. She has a long-demonstrated history of working in the venture capital and private equity industry in corporate development and mergers & acquisitions (M&A). She holds an MA in Economics and a BA in Economics & Political Science, both from Cornell University (USA). She worked until 1999 as a restructuring and turnaround specialist with PriceWaterhouse in New York and Moscow. Cédriane then worked with a portfolio of early-stage tech companies with a venture capital firm, before raising a technology fund and spinning it out to what became Disruptive Capital Finance
Edi Truell has 30 years of financial services experience in private equity and debt markets. In 1998 he formed Duke Street Capital and was chairman of the British Venture Capital Association from 2001 to 2002. He is also a Trustee of The Truell Charitable Foundation and the Charles Darwin Foundation.
In 2010, Edi founded Disruptive Capital Finance, a private equity and venture capital firm specialising in investments in early venture, mid venture, and growth capital. Its investments include The Tungsten Corporation, IRX Therapeutics, Atlantic Superconnection, and Tantalum Corporation. He is founder and architect of the Pension Superfund.
Dr David Brown
Dr Brown has 40 years experience in the pharmaceutical / biotechnology industry both in research and in senior executive roles. Named as co-inventor on the patent for Viagra and later as Global Head of Drug Discovery for Roche.
Dr Brown has a strong interest in entrepreneurialism. He coaches CEOs and entrepreneurs at Centre for Entrepreneurial Learning at Cambridge University Business School and he is an Angel Investor in high-technology start-up companies. He co-founded Crescendo Biologics of which he is currently interim Chair of the board.
He is a Trustee of Antibiotic Research UK